What does Mitsubishi Corporation Life Sciences Venture invest in?
Mitsubishi Corporation Life Sciences Venture invests most often at Series C and Venture (67% of the rounds on record).
Mitsubishi Corporation Life Sciences Venture highlights
- 01
12 rounds on record
- 02
Mostly Series C and Venture: 67% of its rounds
- 03
Sole investor in 1 rounds, median $32M
- 04
6 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first12 appearances
- 2008
2 rounds
- Aug
- Jul
- 2007
1 round
- Jun
- 2005
1 round
- Dec
- 2004
1 round
- Nov
- 2003
2 rounds
- Oct
- Mar
- 2002
2 rounds
- Oct
- Oct
- 2001
3 rounds
- Nov
- Nov
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed6 in all
NetLogic MicrosystemsBought by Broadcom$3.7BSept 2011
Anthera PharmaceuticalsListedUndisclosedMar 2010
NeurogesXListedUndisclosedFeb 2007
Peninsula PharmaceuticalsBought by Johnson & JohnsonUndisclosedApr 2005
Open HarborBought by TradeBeamUndisclosedDec 2004
An exit counts when it came after the firm's first round in the company. From historical deal records.